China National Medicines Co., Ltd. is a pharmaceutical company based in China, specializing in producing special and high-end prescription drugs. Their focus is on providing professional medical services to customers. With a Risk Rating Score of 39.1, the company is classified as high risk. China National Medicines Co., Ltd. operates in the ESG industry and has a main reportable segment, the Commercial segment, which includes pharmaceutical sales. They are also involved in pharmaceutical production, logistics, proprietary Chinese medicines, and chemical preparations.